Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 327

Sort by

Sort Order Select

Journal Articles

FV/FVa revealed

Josefin Ahnström

Blood (2021) 137 (22): 3011–3013.

https://doi.org/10.1182/blood.2021011573

Published: 2021

Journal Articles

Cryo-EM structures of human coagulation factors V and Va

Eliza A. Ruben, Michael J. Rau, James A. J. Fitzpatrick, Enrico Di Cera

Blood (2021) 137 (22): 3137–3144.

https://doi.org/10.1182/blood.2021010684

Published: 2021

Includes: Supplemental data

Journal Articles

Low factor V level ameliorates bleeding diathesis in patients with combined deficiency of factor V and factor VIII

Yanyan Shao, Wenman Wu, Guanqun Xu, Xuefeng Wang, Qiulan Ding

Blood (2019) 134 (20): 1745–1754.

https://doi.org/10.1182/blood.2018886069

Published: 2019

Includes: Supplemental data

Journal Articles

Characterization of the Interaction between Tissue Factor Pathway Inhibitor α (TFPIα) and Factor V Species

Teodolinda Petrillo, PhD, Cornelis Van 't Veer, PhD, Rodney M. Camire, PhD

Blood (2019) 134 (Supplement_1): 485.

https://doi.org/10.1182/blood-2019-130589

Published: 2019

Journal Articles

Hypercoagulability Biomarkers in a New Score Linked to Treatment Resistance for Multiple Myeloma Patients. the Roadmap-MM Study

Loula Papageorgiou, Despina Fotiou, BMBS, MA, Patrick Van Dreden, PhD, Laurent Garderet, MD PhD, Meletios A. Dimopoulos, MD, Ismail Elalamy, MD PhD, Mohamad Mohty, MD PhD, Grigoris Gerotziafas, MD PhD

Blood (2019) 134 (Supplement_1): 1913.

https://doi.org/10.1182/blood-2019-126954

Published: 2019

Journal Articles

Super factor Va, an Engineered Factor V Molecule, Effectively Reduces Bleeding and Acute Coagulopathy in Mouse Models of Trauma and Shock

Bilgimol Chumappumkal Joseph, PhD, Laurent O Mosnier, Annette von Drygalski, MD PharmD

Blood (2019) 134 (Supplement_1): 1101.

https://doi.org/10.1182/blood-2019-124433

Published: 2019

Journal Articles

Novel Pathogenic Genes and Rare Mutations of Congenital Factor V Deficiency: A Case Report

Haixia Guo, MD PhD

Blood (2019) 134 (Supplement_1): 4920.

https://doi.org/10.1182/blood-2019-126350

Published: 2019

Journal Articles

Factor V Leiden Testing and Its Effects on Decision-Making: An Institutional Survey

Tushar Pawar, MD MPH, Ian Garrahy, DO, Anthony Donato, MD MHPE, Amber Stevenson, CMA, Daniel Forman, DO

Blood (2019) 134 (Supplement_1): 4977.

https://doi.org/10.1182/blood-2019-131427

Published: 2019

Journal Articles

Regulation of Coagulation by Polyphosphate

Nicola J. Mutch, BSc, PhD

Blood (2019) 134 (Supplement_1): SCI-18.

https://doi.org/10.1182/blood-2019-121062

Published: 2019

Journal Articles

JNJ-64179375 Inhibits Exosite I-Mediated Thrombin Activity While Preserving Exosite II and Active Site Function in Vitro

Matthew Bunce, PhD, Madhu Chintala, PhD, Sriram Krishnaswamy, PhD, Harlan N Bradford, BA

Blood (2018) 132 (Supplement 1): 24.

https://doi.org/10.1182/blood-2018-99-116291

Published: 2018

Journal Articles

Decreased Factor V Ameliorates Bleeding Diathesis in Patients with Combined Deficiency of Factor V and Factor VIII

Yanyan Shao, PhD, Wenman WU, MD PhD, Guanqun Xu, B.S, Wang Xuefeng, Ding Qiulan

Blood (2018) 132 (Supplement 1): 2503.

https://doi.org/10.1182/blood-2018-99-118350

Published: 2018

Journal Articles

The Tissue Factor Pathway Inhibitor Antibody, PF-06741086, Increases Thrombin Generation in Rare Bleeding Disorder and Von Willebrand Factor Deficient Plasmas

Swapnil Rakhe, MS, Sunita R. Patel-Hett, PhD, Sheryl Bowley, PhD, John E. Murphy, PhD, Debra D Pittman, MS

Blood (2018) 132 (Supplement 1): 2462.

https://doi.org/10.1182/blood-2018-99-119674

Published: 2018

Journal Articles

A Novel Variant of Factor VIII Yields Cofactor Activity without Proteolysis between the A1 and A2 Domains

Manjunath Goolyam Basavaraj, PhD, Sriram Krishnaswamy, PhD

Blood (2018) 132 (Supplement 1): 3771.

https://doi.org/10.1182/blood-2018-99-116267

Published: 2018

Journal Articles

Molecular Analysis of Factor V, Prothrombin and Methylenetetrahydrofolate Redutase in Thrombolic Patients

Aldair Sousa Paiva, PhD, Hugo Diogenes De Oliveira Paiva, MD, Geraldo Barroso Cavalcanti, Jr., PhD, Gioconda DR Leão, PhD, Marcos Dias Leão, PhD, Frank Bahia, MD, Roberto C Vasconcelos, MD, Andrea LAC Fernandes, PhD, Erica Aires Gil, MD, Victor lima Soares, Geisa Januario, Karla Cristina Santos, Telma Araujo Lemos, Alessandra Suelen Jardim

Blood (2018) 132 (Supplement 1): 5050.

https://doi.org/10.1182/blood-2018-99-118777

Published: 2018

Journal Articles

F5 Sequence Variant Identified in 7 Patients Evaluated for Hypercoagulable State with a Factor V (FV) HR2 Assay

Margaret M. Leech, BA, Daniel B. Bellissimo, PhD, John A. Uhrmacher, PhD, Sriya W. Gunawardena, MD, Michael J. Meyer, BA, MS, Franklin A. Bontempo, MD

Blood (2018) 132 (Supplement 1): 5053.

https://doi.org/10.1182/blood-2018-99-114203

Published: 2018

Journal Articles

Thrombin Generation Impairments in Platelet Function Disorders

Justin Brunet, BSc, Subia Tasneem, PhD, Georges E. Rivard, MD FRCPC, Catherine P.M. Hayward, MD

Blood (2018) 132 (Supplement 1): 1150.

https://doi.org/10.1182/blood-2018-99-110247

Published: 2018

Journal Articles

A Plasma-Based Assay to Measure the Susceptibility of Factor V(a) to Inhibition By TFPIα

Tilman M. Hackeng, PhD, Peter van Doorn, MSc, Jan Rosing, PhD, Joost Meijers, PhD, Saskia Middeldorp, MD PhD, Paolo Simioni, MD PhD, Elisabetta Castoldi, PhD

Blood (2018) 132 (Supplement 1): 1168.

https://doi.org/10.1182/blood-2018-99-118767

Published: 2018

Journal Articles

In Newly Diagnosed Multiple Myeloma Patients, Longer Procoagulant Phospholipid-Dependent Clotting Time, Higher Levels of P-Selectin, D-Dimers and Thrombin Generation Peak Are Associated with Increased Risk of Resistance to Treatment: Results of the Prospective Roadmap-MM Study

Grigorios T. Gerotziafas, Despina Fotiou, BMBS, MA, Patrick Van Dreden, PhD, Theodoros N Sergentanis, Ismail Elalamy, MD PhD, Loula Papageorgiou, Matthieu Grusse, Stella Salta, Theodora Psaltopoulou, Annette Larsen, Evangelos Terpos, MD PhD, Meletios A Dimopoulos, MD

Blood (2018) 132 (Supplement 1): 2014.

https://doi.org/10.1182/blood-2018-99-114871

Published: 2018

Journal Articles

Von Willebrand Factor Binding to Myosin Assists in Coagulation

Veronica H Flood, MD, Tricia L Slobodianuk, BS, Daniel A Keesler, BS, Hannah Lohmeier, Scot A Fahs, Robert R Montgomery, MD

Blood (2018) 132 (Supplement 1): 22.

https://doi.org/10.1182/blood-2018-99-113105

Published: 2018

Journal Articles

New Advances Along the Common Coagulation Pathway

Rodney M. Camire, PhD

Blood (2018) 132 (Supplement 1): SCI-44.

https://doi.org/10.1182/blood-2018-99-109557

Published: 2018

NARROW

FV/FVa revealed

Cryo-EM structures of human coagulation factors V and Va

Low factor V level ameliorates bleeding diathesis in patients with combined deficiency of factor V and factor VIII

Characterization of the Interaction between Tissue Factor Pathway Inhibitor α (TFPIα) and Factor V Species

Hypercoagulability Biomarkers in a New Score Linked to Treatment Resistance for Multiple Myeloma Patients. the Roadmap-MM Study

Super factor Va, an Engineered Factor V Molecule, Effectively Reduces Bleeding and Acute Coagulopathy in Mouse Models of Trauma and Shock

Novel Pathogenic Genes and Rare Mutations of Congenital Factor V Deficiency: A Case Report

Factor V Leiden Testing and Its Effects on Decision-Making: An Institutional Survey

Regulation of Coagulation by Polyphosphate

JNJ-64179375 Inhibits Exosite I-Mediated Thrombin Activity While Preserving Exosite II and Active Site Function in Vitro

Decreased Factor V Ameliorates Bleeding Diathesis in Patients with Combined Deficiency of Factor V and Factor VIII

The Tissue Factor Pathway Inhibitor Antibody, PF-06741086, Increases Thrombin Generation in Rare Bleeding Disorder and Von Willebrand Factor Deficient Plasmas

A Novel Variant of Factor VIII Yields Cofactor Activity without Proteolysis between the A1 and A2 Domains

Molecular Analysis of Factor V, Prothrombin and Methylenetetrahydrofolate Redutase in Thrombolic Patients

F5 Sequence Variant Identified in 7 Patients Evaluated for Hypercoagulable State with a Factor V (FV) HR2 Assay

Thrombin Generation Impairments in Platelet Function Disorders

A Plasma-Based Assay to Measure the Susceptibility of Factor V(a) to Inhibition By TFPIα

In Newly Diagnosed Multiple Myeloma Patients, Longer Procoagulant Phospholipid-Dependent Clotting Time, Higher Levels of P-Selectin, D-Dimers and Thrombin Generation Peak Are Associated with Increased Risk of Resistance to Treatment: Results of the Prospective Roadmap-MM Study

Von Willebrand Factor Binding to Myosin Assists in Coagulation

New Advances Along the Common Coagulation Pathway

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only